Bone Solutions Signs Distribution Agreement with Next Health

Bone Solutions (BSI) signed an exclusive 10-state U.S. distribution agreement with Next Health for OsteoCrete magnesium-based bone graft substitute.

BSI is positioned to launch OsteoCrete this summer for U.S. and ex-U.S. extremities markets, and will pursue additional FDA clearance for spinal, dental and craniomaxillofacial applications once...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us